ZNF772
Zinc finger protein 772
Also known as: DKFZp686I1569, ZN772_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68DY9
- Gene
- ZNF772
- Ensembl
- ENSG00000197128
- Chromosome
- 19
- Canonical length
- 489 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
489 residues, UniProt reviewed canonical sequence.
>Q68DY9|ZNF772
1 MAAAEPMGPA QVPMNSEVIV DPIQGQVNFE DVFVYFSQEE WVLLDEAQRL LYRDVMLENF
61 ALMASLGHTS FMSHIVASLV MGSEPWVPDW VDMTLAVATE TPGGSDPGCW HGMEDEEIPF
121 EQSFSIGMSQ IRIPKGGPST QKAYPCGTCG LVLKDILHLA EHQETHPGQK PYMCVLCGKQ
181 FCFSANLHQH QKQHSGEKPF RSDKSRPFLL NNCAVQSMEM SFVTGEACKD FLASSSIFEH
241 HAPHNEWKPH SNTKCEEASH CGKRHYKCSE CGKTFSRKDS LVQHQRVHTG ERPYECGECG
301 KTFSRKPILA QHQRIHTGEM PYECGICGKV FNHSSNLIVH QRVHTGARPY KCSECGKAYS
361 HKSTLVQHES IHTGERPYEC SECGKYFGHK YRLIKHWSVH TGARPYECIA CGKFFSQSSD
421 LIAHQRVHNG EKPYVCSECG KAFSHKHVLV QHHRIHTGER PYKCSECGKA FRQRASLIRH
481 WKIHTGERPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF772 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- retina: 13 nTPM
- parathyroid gland: 10 nTPM
- thyroid gland: 8.5 nTPM
- tongue: 7.3 nTPM
- heart muscle: 6.5 nTPM
- thymus: 5.6 nTPM
Single-cell type
- hematopoietic stem cells: 1 nCPM
- epididymal efferent duct ciliated cells: 0.8 nCPM
- thyrotrophs: 0.8 nCPM
- cardiomyocytes: 0.6 nCPM
- lactotrophs: 0.6 nCPM
- myonuclei: 0.5 nCPM
Immune cell
- naive B-cell: 3.7 nTPM
- memory B-cell: 2.1 nTPM
- naive CD4 T-cell: 1.9 nTPM
- NK-cell: 1.6 nTPM
- myeloid DC: 1.5 nTPM
- MAIT T-cell: 1.3 nTPM
Brain region
- cerebellum: 48 nTPM
- choroid plexus: 33 nTPM
- hypothalamus: 29 nTPM
- cerebral cortex: 28 nTPM
- basal ganglia: 28 nTPM
- midbrain: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF772 as an antibody target. Whether an autoantibody or antibody against ZNF772 could matter depends on whether native ZNF772 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF772 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF772 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...